These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4060879)

  • 1. [Lipid-bound serum sialic acids in the complex diagnosis of recurrences of cancer of the ovary].
    Bassalyk LS; Novikov AM; Makhova EE; Kozachenko VP
    Vestn Akad Med Nauk SSSR; 1985; (9):67-70. PubMed ID: 4060879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of lipid-bound sialic acid levels in the diagnosis of recurrences of cancer of the rectum].
    Ozhiganov EL; Novikov AM; Bassilyk LS
    Lab Delo; 1987; (3):204-7. PubMed ID: 2438465
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum lipid-bound sialic acid assay for detection of ovarian neoplasm].
    Chen SP
    Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):235-8. PubMed ID: 6675922
    [No Abstract]   [Full Text] [Related]  

  • 4. [Circulating lipid-bound sialic acid levels in patients with malignant tumors].
    Bassalyk LS; Novikov AM; Sokolova VD; Sorokin EN
    Vopr Med Khim; 1984; 30(3):124-7. PubMed ID: 6474937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of sialic acid and carcinoembryonic antigen as monitors of tumor burden among patients with carcinoma of the ovary.
    Silver HK; Karim KA; Salinas FA; Swenerton KD
    Surg Gynecol Obstet; 1981 Aug; 153(2):209-13. PubMed ID: 7244990
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K; Bian M; Zhu D; Liu W; Siu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in serum sialic acid levels in patients with ovarian tumors in the process of treatment].
    Travnikov ME; Novikov AM; Varazashvili LM; Bassalyk LS; Kozachenko VP
    Akush Ginekol (Mosk); 1990 Jul; (7):61-3. PubMed ID: 2240453
    [No Abstract]   [Full Text] [Related]  

  • 8. A case control study of glycoprotein status in ovarian carcinoma.
    Aranganathan S; Senthil K; Nalini N
    Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood serum sialic acids in the diagnosis of ovarian tumors].
    Makhova EE; Novikov AM; Bassalyk LS
    Akush Ginekol (Mosk); 1985 Mar; (3):54-5. PubMed ID: 3161370
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
    Rajpura KB; Patel PS; Chawda JG; Shah RM
    J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on correlation between alterations in serum sialic acid levels and remission, metastasis, and recurrence of diseases in patients with cancer (author's transl)].
    Chen YQ; Zhou YQ; Yu SY
    Zhonghua Zhong Liu Za Zhi; 1979; 1(1):29-34. PubMed ID: 552354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sialic acids in lymphogranulomatosis].
    Novikov AM; Sorokin EN; Bassalyk LS
    Ter Arkh; 1984; 56(6):75-7. PubMed ID: 6474378
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic value of determining the levels of lipid-bound sialic acids in the blood in cancer of the kidneys].
    Rubtsov BI; Novikov AM; Figurin KM
    Urol Nefrol (Mosk); 1988; (3):31-3. PubMed ID: 3218004
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor markers in epithelial ovarian cancer. Clinical applications.
    Hempling RE
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):41-61. PubMed ID: 8015766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of serum acute-phase reactants in patients with ovarian tumors.
    Warwas M; Dobryszycka W; Gerber J; Pietkiewicz A
    Neoplasma; 1981; 28(4):485-90. PubMed ID: 7290269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-bound sialic acid as a tumor marker.
    Dnistrian AM; Schwartz MK
    Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipid bound sialic acid in patients with prostate and bladder cancer.
    Dunzendorfer U; Katopodis N; Dnistrian AM; Stock CC; Schwartz MK; Whitmore WF
    Invest Urol; 1981 Nov; 19(3):194-6. PubMed ID: 7298291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Total and lipid-bound sialic acids in the sera of patients with cancer of the stomach and large intestine].
    Oki S
    Nihon Gan Chiryo Gakkai Shi; 1983 Apr; 18(3):692-703. PubMed ID: 6619635
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum concentrations of lipid bound sialic acid and acute phase proteins in patients with cancer and nonmalignant disease.
    Raynes JG
    Biomed Pharmacother; 1983; 37(3):136-8. PubMed ID: 6605767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sialic acid--an important cancer marker.
    Tewarson SL; Mittal VP; Singh M; Gupta GP
    Indian J Cancer; 1993 Sep; 30(3):125-31. PubMed ID: 8300142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.